Ketamine infusions 2μg 4μg and 6μg / kg / min will be started preoperatively in group 1, 2 and 3 respectively when sensory block level reaches T10 after spinal anesthesia, and they will be reduced by half by the end of the operation. Ketamine infusion will be continued for 48 hours postoperatively.
Low Dose Ketamine Infusion for Postoperative Analgesia After Total Knee Arthroplasty
Brief Summary
This study evaluates continous infusion of low-dose ketamine during intraoperative and postoperative periods at three different doses to provide postoperative analgesia in total knee arthroplasty cases. Patients enrolled randomly into one of 2, 4, 6 μg / kg / min perioperative ketamine groups. All groups were given spinal anesthesia and intravenous patient controlled anesthesia. Ketamine was started when sensorial block reached T10 dermatome level before the skin incision. By the end of the operation, in all groups, ketamine infusions were reduced by half doses. Intravenous patient-controlled analgesia device was set to 2 mg bolus morphine with no basal infusion for 48 hours during the postoperative period.
Study Design
| Study type: | OBSERVATIONAL |
|---|---|
| Status: | Completed |
| Study results: | No Results Available |
| Age: | 18 Years and older (Adult, Older Adult) |
| Enrollment: | 75 (ACTUAL) |
| Funded by: | Other |
| Time Perspective: | Prospective |
| Observational Model: | Case-Control |
Masking |
|
Clinical Trial Dates
| Start date: | Apr 15, 2019 | ACTUAL |
|---|---|---|
| Primary Completion: | Sep 02, 2021 | ACTUAL |
| Completion Date: | Sep 02, 2021 | ACTUAL |
| Study First Posted: | Sep 11, 2019 | ACTUAL |
| Results First Posted: | Aug 31, 2020 | |
| Last Updated: | Sep 13, 2021 |
Sponsors / Collaborators
Lead Sponsor:
N/A
Responsible Party:
N/A
Location
Multimodal analgesia, which involves the administration of two or more analgesic agents targeting different levels of pain pathways, is used to improve pain control while also to reduce opioid use and related side effects. Pain can be treated at various neurophysiological levels, including peripheral, spinal and cortical targets. One of the agents used in the multimodal analgesia technique is ketamine.
Ketamine acts on the central nervous system (CNS) and has local anesthetic effect. Ketamine is an N-methyl D-Aspartate (NMDA) receptor antagonist, which appears to be the main mechanism of anesthetic and analgesic action at CNS and spinal cord receptors. Other mechanisms of action of ketamine include the interaction with opioid receptors, particularly mu and kappa receptors. Another effect is that it has local anesthetic effect in high doses. Studies have shown that ketamine is an effective agent in the treatment of postoperative pain. Continuous infusion of low-dose ketamine after total knee arthroplasty significantly reduced morphine consumption, and provided early rehabilitation without increasing side effects. However, when these studies are considered, there is no information about the optimal dose of ketamine that reduces opioid consumption at the highest level.
In our study, continuous infusion of low-dose ketamine at different doses was planned to provide postoperative analgesia. Therefore, our first aim in this study was to find out the optimal dose that reduced morphine consumption for postoperative analgesia after TKA with continuous ketamine infusion at different doses. The secondary objectives are to evaluate early and late period pain, side effects, length of hospital stay, patient satisfaction, and recovery.
Ketamine acts on the central nervous system (CNS) and has local anesthetic effect. Ketamine is an N-methyl D-Aspartate (NMDA) receptor antagonist, which appears to be the main mechanism of anesthetic and analgesic action at CNS and spinal cord receptors. Other mechanisms of action of ketamine include the interaction with opioid receptors, particularly mu and kappa receptors. Another effect is that it has local anesthetic effect in high doses. Studies have shown that ketamine is an effective agent in the treatment of postoperative pain. Continuous infusion of low-dose ketamine after total knee arthroplasty significantly reduced morphine consumption, and provided early rehabilitation without increasing side effects. However, when these studies are considered, there is no information about the optimal dose of ketamine that reduces opioid consumption at the highest level.
In our study, continuous infusion of low-dose ketamine at different doses was planned to provide postoperative analgesia. Therefore, our first aim in this study was to find out the optimal dose that reduced morphine consumption for postoperative analgesia after TKA with continuous ketamine infusion at different doses. The secondary objectives are to evaluate early and late period pain, side effects, length of hospital stay, patient satisfaction, and recovery.
Eligibility Criteria
| Sex: | Female |
|---|---|
| Minimum Age: | 18 |
| Healthy Volunteers: | Yes |
Inclusion Criteria:
• ASA I-Ⅲ female patients scheduled for unilateral total knee arthroplasty
Exclusion Criteria:
* Patients younger than 18 years of age
* ASA Ⅳ and above patients
* Having previous knee surgery on the same side
* Patients with allergies to drugs to be used in the study
* Contraindication for spinal anesthesia
* Body mass index 40 kg / m2 and above patients
* Opioid tolerance
* Patients with neurological or psychiatric disorders
* Patients who do not have the ability to use patient controlled analgesia device
• ASA I-Ⅲ female patients scheduled for unilateral total knee arthroplasty
Exclusion Criteria:
* Patients younger than 18 years of age
* ASA Ⅳ and above patients
* Having previous knee surgery on the same side
* Patients with allergies to drugs to be used in the study
* Contraindication for spinal anesthesia
* Body mass index 40 kg / m2 and above patients
* Opioid tolerance
* Patients with neurological or psychiatric disorders
* Patients who do not have the ability to use patient controlled analgesia device
Primary Outcomes
Secondary Outcomes
-
The pain status of the patients at rest and in motion with 100 mm visual pain scale (VAS) (0= no pain and 100 = intolerable pain) will be evaluated and recorded preoperative and postoperative at 2nd, 6th, 12th, 24th and 48th hours.and after 3 months
-
Nausea, vomiting, itching, respiratory depression, hallucination and diplopia
-
Hospital stay (as day) required for active knee flexion to 90 degrees (measured with goniometer) will be recorded.
-
5 point likert scale
More Details
| NCT Number: | NCT04085588 |
|---|---|
| Other IDs: | 15.04.2019-07 |
| Study URL: | https://clinicaltrials.gov/study/NCT04085588 |
Last updated: Sep 29, 2023